Thu, April 11, 2024
Wed, April 10, 2024
Tue, April 9, 2024

Reni Benjamin Reiterated (BPMC) at Buy and Held Target at $114 on, Apr 10th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-114-on-apr-10th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Reni Benjamin of JMP Securities, Reiterated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $114 on, Apr 10th, 2024.

Reni has made no other calls on BPMC in the last 4 months.



There are 7 other peers that have a rating on BPMC. Out of the 7 peers that are also analyzing BPMC, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $70 on, Tuesday, February 13th, 2024


These are the ratings of the 6 analyists that currently disagree with Reni


  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $97 on, Monday, February 26th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $65 on, Friday, February 16th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $97 on, Tuesday, January 9th, 2024
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $100 on, Friday, December 22nd, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Tuesday, December 19th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Monday, December 11th, 2023

Publication Contributing Sources